Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
BEOVU Inj Lös 6 mg/0.05ml Fertigspr 0.165 ml
Drug
Beovu, Injektionslösung in Fertigspritze
altersbedingte Makuladegeneration (AMD) und diabetisches Makulaödem (DME)
11.99.0. – various
HAM – Human medicine
LSINJ – Solution for injection
BT – biological medicines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
1/16/2020
1/15/2025
Dosage strength
Beovu 120mg/1ml, Injektionslösung in Fertigspritze
altersbedingte Makuladegeneration (AMD) und diabetisches Makulaödem (DME)
01
Z – approved
Package
7680672440019
No information made available
A/R – Authorised / referenced
1 pre-filled syringe(s)
001
Z – approved
Declaration
Component
120 mg brolucizumabum
saccharum
natrii citras anhydricus
polysorbatum 80
natrii hydroxidum
aqua ad iniectabile
natrii citras anhydricus
polysorbatum 80
natrii hydroxidum
aqua ad iniectabile
Spezialitätenliste***
SL
-
-
766.70
None
Yes
10%
No
Authorisation holder
7601001300477
Novartis Pharma Schweiz AG
6343 Risch (ZG)
6343 Risch (ZG)
Date of revision of the text
5/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.